xolair
novartis europharm limited - omalizumab - asthma; urticaria - drogy obštrukčnej choroby dýchacích ciest, - alergické asthmaxolair je indikovaný u dospelých, dospievajúcich a detí (od 6 do.
asmanex 400 µg
n.v. organon, holandsko - mometazón - 14 - bronchodilatantia, antiasthmatica
asmanex 200 µg
n.v. organon, holandsko - mometazón - 14 - bronchodilatantia, antiasthmatica
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - drogy obštrukčnej choroby dýchacích ciest, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - drogy obštrukčnej choroby dýchacích ciest, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
mofuder 1 mg/g
bausch health ireland limited, Írsko - mometazón - 46 - dermatologica
elocom masť
n.v. organon, holandsko - mometazón - 46 - dermatologica
elocom krém
n.v. organon, holandsko - mometazón - 46 - dermatologica
elocom roztok
n.v. organon, holandsko - mometazón - 46 - dermatologica
mometasone sandoz 50 mikrogramov
sandoz pharmaceuticals d.d., slovinsko - mometazón - 69 - otorhinolaryngologica